Dana M.
@DanaDoesScience
Followers
41
Following
36
Media
1
Statuses
10
Cancer biology PhD candidate. Lover of good beer, live music, and the outdoors.
University of Michigan
Joined July 2022
Star PhD student @DanaDoesScience wrote this blog post describing the very complex way H3K27M mutations cause DIPG/DMGs in a way that's **accessible to non-experts**. Beautifully written and a great resource for patients, families, and non-experts alike!
misciwriters.com
Written and illustrated by: Dana Messinger Edited by: Olivia Pifer Alge, Julia Donovan, and Jennifer Baker In September 2014, Ann Arbor local Chad Carr, grandson of University of Michigan football …
2
9
45
Thank you Swenson family! So lucky to be involved in such important work
We had an incredible visit from the Swenson family in the lab yesterday. The Swenson's lost their daughter Marit to an H3K27M DMG in 2017. Their foundation https://t.co/LIrqPjzYgT donated $22k in honor of Merit to support our graduate student @DanaDoesScience
1
0
6
Was lucky enough to get to present my poster at the @NeuroOnc conference last weekend! @KoschmannLab
0
3
9
It was such an honor to win a poster award at the @CBTNetwork summit! Thanks for a day of such interesting talks!
Had a blast yesterday catching up with colleagues at the @CBTNetwork Scientific Summit in DC! We had four posters on various projects in the lab and two won top poster awards! Congrats to @DanaDoesScience and Sunny Ji! @UmichCancBio #DIPG
0
0
3
Thank you @chadtough and @tamcarr21 for organizing this amazing event to defeat DIPG! @MarkWMosier @JennyMosier @MottChildren @UMRogelCancer #DIPG
1
4
23
Amazing to host Meghan Behen and little Mac from the #MorganBehenGolfClassic. Meghan hand delivered a check to fund a new qPCR machine in lab (!!!) We are so grateful for your generosity and will continue to fight for DIPG patients and families #MorganStrong #EndDIPG
0
3
26
New review from our lab published in @FrontOncology (led by MDPhD student Kallen Schwark and @vivekanandVNY @ResearchCM) describing the existing state of targeted tyrosine kinase inhibitor use in preclinical models and clinical trials of pediatric high-grade glioma. Check it out!
New research: Receptor tyrosine kinase (RTK) targeting in pediatric high-grade glioma and diffuse midline glioma: Pre-clinical models and precision medicine: Pediatric high-grade glioma (pHGG), including both diffuse midline glioma (DMG) and… https://t.co/JuOv2c9Z6e
#oncology
0
8
16
Congrats! It was great to collaborate on this project and glad to have you here. Look out for more work by @jackwadden developing rapid, easy-to-perform, accurate, and low-cost liquid biopsy assays to track treatment response in our #DMG/#DIPG peds patients.
0
5
13
New paper out from our lab! Targeting the “diffuse” in diffuse midline glioma? Pediatric brain tumor cell invasion and migration can be slowed through inhibition of the protein ID1. Quick explainer🧵below by first author @DanaDoesScience ... 1/n
academic.oup.com
AbstractBackground. Diffuse midline gliomas (DMG) are highly invasive brain tumors with rare survival beyond two years past diagnosis and limited understan
2
11
58